IWGDF 2024 Recommendations on Antimicrobial Dressings for Diabetic Foot Ulcers

Recommendation Against Antimicrobial Dressings

• The International Working Group on the Diabetic Foot (IWGDF) 2024 guideline issues a strong recommendation with moderate certainty of evidence to avoid all topical antiseptic or antimicrobial dressings, including cadexomer iodine, for wound‑healing purposes in diabetes‑related foot ulcers. 1

Standard Wound‑Healing Care

• Sharp debridement is identified as the primary intervention for diabetic foot ulcers; the frequency should be tailored to the individual’s clinical need. 5
• Basic wound dressings that absorb exudate and maintain a moist wound environment are recommended as the foundational dressing type. 4

Situations Requiring Antimicrobial Treatment

• When a diabetic foot ulcer is clinically infected, antimicrobial management follows infection‑specific protocols rather than the wound‑healing protocol that advises against antimicrobial dressings. 1

Alternative Dressings for Non‑Infected Ulcers

• For non‑infected neuro‑ischemic ulcers that do not improve after two weeks of standard care, a sucrose‑octasulfate‑impregnated dressing may be considered as an adjunctive option. 6

Regulatory Context

• Although the FDA label for cadexomer iodine suggests application 1–3 times daily for up to one week, the IWGDF disease‑specific guideline supersedes this labeling and recommends against its use for wound‑healing in diabetic foot ulcers. 1

Bottom‑Line Clinical Action

• Zero applications of cadexomer iodine should be employed with the intent of promoting wound healing in diabetic foot ulcers; clinicians should instead prioritize sharp debridement and appropriate basic dressings. 1